INS and type 2 diabetes mellitus: About 90% of people living with diabetes have type 2 diabetes (T2D), a condition driven by resistance to the action of insulin such that the ensuing hyperglycaemia is also associated with a range of dysmetabolic and inflammatory sequelae that converge to cause a 2–3‐fold increased risk of cardiovascular complications [4].